NCT02050074View on ClinicalTrials.gov

The Role of Metformin and Colesevelam in Human GLP-1 Secretion

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

Colesevelam

DRUG

Metformin

OTHER

Placebo

Trial Locations (1)

2900

Diabetes Research Division, Department of Medicine, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02050074 - The Role of Metformin and Colesevelam in Human GLP-1 Secretion | Biotech Hunter | Biotech Hunter